• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Iron homeostasis alterations and risk for akathisia in patients treated with antipsychotics: A systematic review and meta-analysis of cross-sectional studies.
 

Iron homeostasis alterations and risk for akathisia in patients treated with antipsychotics: A systematic review and meta-analysis of cross-sectional studies.

Options
  • Details
BORIS DOI
10.7892/boris.144319
Date of Publication
June 2020
Publication Type
Article
Division/Institute

Institut für Sozial- ...

Contributor
Schoretsanitis, Georgios
Nikolakopoulou, Adriani
Institut für Sozial- und Präventivmedizin (ISPM)
Guinart, Daniel
Correll, Christoph U
Kane, John M
Subject(s)

600 - Technology::610...

300 - Social sciences...

Series
European neuropsychopharmacology
ISSN or ISBN (if monograph)
0924-977X
Publisher
Elsevier
Language
English
Publisher DOI
10.1016/j.euroneuro.2020.04.001
PubMed ID
32444336
Uncontrolled Keywords

Akathisia Antipsychot...

Description
Iron homeostasis may be implicated in the pathophysiology of antipsychotic-related akathisia. We performed a systematic review in six databases from database inception until 03/2020, conducting a meta-analysis of studies investigating iron metabolism in antipsychotic-treated patients with versus without akathisia. Using a fixed- and a random-effects model, standardized mean difference (SMD) was estimated for levels of iron, ferritin, transferrin and total iron-binding capacity. Meta-regression analyses included sex, age, illness duration and antipsychotic treatment and dose. Subgroup analyses included chronic vs. acute akathisia and different diagnoses. Study quality was assessed using the Newcastle-Ottawa scale. In 10 studies (n = 395), compared to non-akathisia patients (n = 213), iron levels were lower in patients with akathisia (n = 182; fixed-effect model: SMD=-0.49, 95%CI=-0.28,-0.70, p<0.001; random-effects model: SMD=-0.55, 95%CI=-0.14,-0.96, p = 0.008). For secondary outcomes, differences were significant regarding lower ferritin levels in patients with akathisia in the fixed-effect model (SMD=-0.32, 95%CI=-0.08,-0.55, p = 0.007), but not in the random-effects model (SMD=-0.29, 95%CI=0.20,-0.79, p = 0.24). None of the moderators/mediators had a significant effect on the group difference of iron levels. Subgroup analyses reported lower iron levels in both patients with chronic and acute akathisia vs. patients without. Iron levels for schizophrenia patients were lower in the fixed-effect model (SMD=-0.55, 95%CI=-0.23, -0.86, p<0.001), while a trend was observed in the random-effects model (SMD=-0.52, 95%CI=-0.07, -1.12, p = 0.08). The studies' quality was overall poor, with one exception. This meta-analysis suggests lower iron levels in akathisia patients, while ferritin differences were significant only in the fixed-effect model. Further data are required to promote the understanding of related pathways.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/36062
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
Schoretsanitis EurNeuropsychopharmacol 2020_AAM.pdfAdobe PDF910.09 KBAttribution-NonCommercial-NoDerivatives (CC BY-NC-ND 4.0)acceptedOpen
Schoretsanitis EurNeuropsychopharmacol 2020.pdfAdobe PDF1.52 MBpublisherpublished restricted
BORIS Portal
Bern Open Repository and Information System
Build: 27ad28 [15.10. 15:21]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo